These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 21167085

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Oral mucosal irritation with incorrect use of alendronate.
    Aleid W, Sidebottom A.
    Br J Oral Maxillofac Surg; 2009 Mar; 47(2):170-1. PubMed ID: 18814944
    [No Abstract] [Full Text] [Related]

  • 3. Oral ulcer associated with alendronate: a case report.
    Kharazmi M, Sjöqvist K, Rizk M, Warfvinge G.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Dec; 110(6):e11-3. PubMed ID: 20674418
    [Abstract] [Full Text] [Related]

  • 4. In brief: effervescent alendronate.
    Med Lett Drugs Ther; 2012 Oct 15; 54(1401):84. PubMed ID: 23059422
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Retrospective study of two biochemical markers for the risk assessment of oral bisphosphonate-related osteonecrosis of the jaws: can they be utilized as risk markers?
    Kwon YD, Ohe JY, Kim DY, Chung DJ, Park YD.
    Clin Oral Implants Res; 2011 Jan 15; 22(1):100-5. PubMed ID: 20946206
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Reports of esophageal cancer with oral bisphosphonate use.
    Wysowski DK.
    N Engl J Med; 2009 Jan 01; 360(1):89-90. PubMed ID: 19118315
    [No Abstract] [Full Text] [Related]

  • 16. Zenker's diverticulitis secondary to alendronate ingestion: a rare cause of recurrent dysphagia.
    Sharma R, DeCross AJ.
    Gastrointest Endosc; 2011 Feb 01; 73(2):368-70. PubMed ID: 21295647
    [Abstract] [Full Text] [Related]

  • 17. [Use of optical coherence tomography for prognosis of the severity of oral mucositis].
    Maslennikova AV, Balalaeva IV, Gladkova ND, Karabut MM, Kiseleva EB, Iksanov RR, Il'in NI, Sokurenko VP.
    Vopr Onkol; 2009 Feb 01; 55(5):572-9. PubMed ID: 20020652
    [Abstract] [Full Text] [Related]

  • 18. [Osteoporosis and bisphosphonates].
    Zuber MA.
    Z Rheumatol; 2007 Dec 01; 66(8):713-5. PubMed ID: 17955251
    [No Abstract] [Full Text] [Related]

  • 19. Common musculoskeletal adverse effects of oral treatment with once weekly alendronate and risedronate in patients with osteoporosis and ways for their prevention.
    Bock O, Boerst H, Thomasius FE, Degner C, Stephan-Oelkers M, Valentine SM, Felsenberg D.
    J Musculoskelet Neuronal Interact; 2007 Dec 01; 7(2):144-8. PubMed ID: 17627083
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: a randomized, multicenter, double-blind, active-controlled study.
    Orwoll ES, Miller PD, Adachi JD, Brown J, Adler RA, Kendler D, Bucci-Rechtweg C, Readie A, Mesenbrink P, Weinstein RS.
    J Bone Miner Res; 2010 Oct 01; 25(10):2239-50. PubMed ID: 20499357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.